Trial Profile
An open, randomized, single-center study assessing the serum time-concentration curves and the effect of prophylactic moxifloxacin (in comparison with cefuroxime) on the early inflammatory response to cardiopulmonary bypass in patients undergoing coronary artery bypass grafting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2011
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary) ; Cefuroxime
- Indications Bacterial infections; Postoperative infections
- Focus Therapeutic Use
- 11 Jun 2011 New trial record